Innovations Driving the Global Antibody Drug Conjugates Market
Increasing awareness about precision medicine is encouraging healthcare providers to adopt targeted therapies such as antibody drug conjugates. These therapies are designed to attack specific cancer cells while minimizing damage to healthy tissues. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in...
0 التعليقات 0 المشاركات 19 مشاهدة 0 معاينة
Lifesone https://lifesone.com